ArticleLancet regional health. Americas2026
Associations between state-level abortion restrictions and postpartum depression symptoms from a United States nationwide cohort.
Article in Lancet regional health. Americas, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: U.S. maternal mortality rates have more than doubled over the last two decades, with maternal mental health conditions being significant contributors. Concurrently, the adoption of U.S. state-level restrictions on abortion access have also increased. We aimed to examine the association between the number of state-level abortion restrictions and postpartum depression symptoms in a U.S. nationwide cohort. Methods: This retrospective cohort study compared state-level abortion restriction policy data from the Guttmacher Institute from each preceding year (2016-2021) to rates of postpartum depression symptoms collected from the nationally representative Pregnancy Risk Assessment Monitoring System (PRAMS) Phase 8 (2017-2022) dataset. PRAMS participants were randomly selected from 41 participating states' birth registries, representing 30·4% of U.S. live births. The primary outcome was postpartum depression symptoms, assessed using validated screening questions. Secondary outcomes included demographic and clinical predictors of postpartum depression. Variables found to be significant on bivariate analysis were included in the logistic multivariable model. People with lived experience were involved in the design, analysis, and interpretation of this study. Findings: The sample included 201,770 respondents, weighted to represent 5·65 million individuals. The mean age was 29·7 years, with 72·6% identifying as White and 57·9% having private insurance. Higher numbers of state-level abortion restrictions were associated with increased odds of postpartum depression symptoms (OR = 1·02, 95% CI [1·01, 1·03], p = 0·001), particularly among those relying on public insurance (OR = 1·02, 95% CI [1·01-1·04], p = 0·002). This association was particularly pronounced among racial and ethnic minorities, individuals with a history of depression, and those with lower levels of education or income who gave birth in high-restriction states. Interpretation: The adoption of more abortion restrictions is linked to higher prevalence of postpartum depression symptoms, especially for those with public insurance. These findings show that restricted abortion has detrimental effects on perinatal mental health, highlighting the need for policy reforms. Funding: No funding was provided for this study, funding from Brigham and Women's Hospital, Mary Horrigan Connors Center for Women's Health Research was provided for journal editorial processing fees.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.